Viewing Study NCT01160094


Ignite Creation Date: 2025-12-25 @ 1:44 AM
Ignite Modification Date: 2026-03-06 @ 9:38 PM
Study NCT ID: NCT01160094
Status: COMPLETED
Last Update Posted: 2016-03-28
First Post: 2010-07-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO)
Sponsor: Novartis
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module